Fundraising Fox
/People
Sign in

Michael Taylor

Investor

Operating Partner at Mission Biocapital · Executive at Deciphera Pharmaceuticals · Director at Telo Therapeutics, Inc. · Executive Chairman at ARase Therapeutics

Cambridge

Find your path to Michael

428 people in our graph share verified history with Michael — schools, employers, funds. One of them is your warm intro.

Rajesh DevrajunlockedMichael: together at Deciphera (2014)
×11Michael: together at Mission Biocapital

About

Operating Partner in the Cambridge office providing management and operational leadership to portfolio companies, serving as Executive Chairman at several. Former President and CEO of Deciphera Pharmaceuticals and CEO of Ensemble Therapeutics. Holds a PhD in Medicinal Chemistry from SUNY Buffalo.

Executive at Deciphera Pharmaceuticals

Intro paths

→

In turn, Michael can intro founders to Deciphera Pharmaceuticals's investors below.

Deciphera Pharmaceuticals's investors · 3

Frazier Life SciencesPalo Alto · since 2017REDMILESan Francisco · since 2017Viking Global InvestorsStamford · since 2017

Co-founders at Deciphera Pharmaceuticals

DF
Daniel F. Flynn, Ph.D.Executive Officer

Director at Telo Therapeutics, Inc.

Intro paths

→

In turn, Michael can intro founders to Telo Therapeutics, Inc.'s investors below.

Telo Therapeutics, Inc.'s investors · 1

Mission BiocapitalSan Francisco · $500K checks · since 2022

Co-founders at Telo Therapeutics, Inc.

RB
Rob BellFounder
RB
Robert Bell Ph.D.CEO & Co-Founder

Executive Chairman at ARase Therapeutics

Intro paths

→

In turn, Michael can intro founders to ARase Therapeutics's investors below.

ARase Therapeutics's investors · 2

Mission BiocapitalSan Francisco · $500K checks · since 2021Portal InnovationsChicago

Co-founders at ARase Therapeutics

PCPaul Chang
Paul ChangPresident, CEO / CSO and Lead Founder
WLW. Lee Kraus
W. Lee KrausScientific Founder

Experience

  1. Mission BioCapitalOperating Partnercurrent2020 — present
  2. Deciphera PharmaceuticalsDirector2014 — 2021
  3. Deciphera Pharmaceuticals, Inc.Senior Advisor2019Waltham, Massachusetts
  4. Deciphera Pharmaceuticals, Inc.President & CEO2014 — 2019Waltham, Massachusetts
  5. Ensemble Therapeutics Corp.President & CEO2007 — 2013
  6. Marina BiotechDirector2010 — 2012
  7. Cequent PharmaceuticalsDirector2008 — 2010
  8. PfizerSenior Vice President2000 — 2007
  9. PfizerDrug Development Vice President1983 — 2000
  10. Parke-Davis Pharmaceutical ResearchDrug Development VP1998 — 2000

Skills & more

Medicinal Chemistry3Biomarkers2Strategy9Drug Discovery12Drug Development22Lifesciences6Clinical Development7Biotechnology10Molecular Biology1Pharmaceutical Industry9Oncology3Genomics1
+3 moreTechnology TransferAssay DevelopmentBiopharmaceuticals

From Michael's professional profile.

Deals · 1

Telo Therapeutics, Inc.Board seat

via Mission Biocapital · filed Jun 2022 · $10.2M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Mission Biocapital

Cassidy Blundell
Partner at Mission Biocapital
Chaya Patel
Principal at Mission Biocapital
Chris Carlin
Chief Operations Officer and Chief Compliance Officer at Mission Biocapital
Clay Rowland
Investment Associate at Mission Biocapital
Douglas Crawford
Managing General Partner at Mission Biocapital
Jennifer Griffin
Partner at Mission Biocapital
Johannes Fruehauf
General Partner at Mission Biocapital
Josephine Brysting
Investment Analyst at Mission Biocapital

Frequently asked questions

Who is Michael Taylor?
Operating Partner in the Cambridge office providing management and operational leadership to portfolio companies, serving as Executive Chairman at several. Former President and CEO of Deciphera Pharmaceuticals and CEO of Ensemble Therapeutics. Holds a PhD in Medicinal Chemistry from SUNY Buffalo.
Where does Michael Taylor work?
Michael Taylor is Operating Partner at Mission Biocapital and Executive at Deciphera Pharmaceuticals and Executive Chairman at ARase Therapeutics.
What boards does Michael Taylor sit on?
Michael Taylor holds tracked board seats at Telo Therapeutics, Inc..
Where did Michael Taylor go to school?
Michael Taylor studied at University of Pennsylvania (Post-Doc, Organic Chemistry); University at Buffalo (Ph.D., Medicinal Chemistry); University of South Florida (B.S., Chemistry).

Same school

Shared employers